kava noble cultivar
Selected indexed studies
- Kava hepatotoxicity: pathogenetic aspects and prospective considerations. (Liver Int, 2010) [PMID:20630022]
- Kava hepatotoxicity solution: A six-point plan for new kava standardization. (Phytomedicine, 2011) [PMID:21112196]
- Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence. (Phytother Res, 2011) [PMID:21442674]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Kava hepatotoxicity: pathogenetic aspects and prospective considerations. (2010) pubmed
- Kava hepatotoxicity solution: A six-point plan for new kava standardization. (2011) pubmed
- Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence. (2011) pubmed
- Re-introduction of kava (Piper methysticum) to the EU: is there a way forward? (2011) pubmed
- Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial. (2015) pubmed
- Contaminant hepatotoxins as culprits for kava hepatotoxicity--fact or fiction? (2013) pubmed
- Detection of flavokavins (A, B, C) in cultivars of kava (Piper methysticum) using high performance thin layer chromatography (HPTLC). (2014) pubmed
- Comparative analysis of genetic variation in kava (Piper methysticum) assessed by SSR and DArT reveals zygotic foundation and clonal diversification. (2015) pubmed